TARRYTOWN, N.Y., Oct. 14, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that the U.S. Food and Drug Administration (FDA) approved Inmazeb (atoltivimab,
Read moreHome ยป
Broken bones could regrow after injury using a drug cocktail that triggers the release of ‘red alert’ repair cells Two drugs already available have been
Read more